Your browser doesn't support javascript.
loading
Loss of expression of both miR-15/16 loci in CML transition to blast crisis.
Lovat, Francesca; Gasparini, Pierluigi; Nigita, Giovanni; Larkin, Karilyn; Byrd, John C; Minden, Mark D; Andreeff, Michael; Carter, Bing Z; Croce, Carlo M.
Afiliação
  • Lovat F; Department of Cancer Biology and Genetics, The Ohio State University, Columbus, OH 43210.
  • Gasparini P; Comprehensive Cancer Center, The Ohio State University, Columbus, OH 43210.
  • Nigita G; Department of Cancer Biology and Genetics, The Ohio State University, Columbus, OH 43210.
  • Larkin K; Comprehensive Cancer Center, The Ohio State University, Columbus, OH 43210.
  • Byrd JC; School of Biomedical Sciences and Pharmacy, University of Newcastle, Newcastle, 2308 NSW, Australia.
  • Minden MD; Department of Cancer Biology and Genetics, The Ohio State University, Columbus, OH 43210.
  • Andreeff M; Comprehensive Cancer Center, The Ohio State University, Columbus, OH 43210.
  • Carter BZ; Comprehensive Cancer Center, The Ohio State University, Columbus, OH 43210.
  • Croce CM; Division of Hematology, The Ohio State University Comprehensive Cancer Center, Columbus, OH 43210.
Proc Natl Acad Sci U S A ; 118(11)2021 03 16.
Article em En | MEDLINE | ID: mdl-33836616
Despite advances that have improved the treatment of chronic myeloid leukemia (CML) patients in chronic phase, the mechanisms of the transition from chronic phase CML to blast crisis (BC) are not fully understood. Considering the key role of miR-15/16 loci in the pathogenesis of myeloid and lymphocytic leukemia, here we aimed to correlate the expression of miR-15a/16 and miR-15b/16 to progression of CML from chronic phase to BC. We analyzed the expression of the two miR-15/16 clusters in 17 CML patients in chronic phase and 22 patients in BC and in 11 paired chronic phase and BC CML patients. BC CMLs show a significant reduction of the expression of miR-15a/-15b/16 compared to CMLs in chronic phase. Moreover, BC CMLs showed an overexpression of miR-15/16 direct targets such as Bmi-1, ROR1, and Bcl-2 compared to CMLs in chronic phase. This study highlights the loss of both miR-15/16 clusters as a potential oncogenic driver in the transition from chronic phase to BC in CML patients.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia Mielogênica Crônica BCR-ABL Positiva / Crise Blástica / MicroRNAs Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia Mielogênica Crônica BCR-ABL Positiva / Crise Blástica / MicroRNAs Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article